In the last couple of weeks the market seems to have been trying to resolve the contradiction of the world we’re in right now. State governments began lifting COVID-19-induced restrictions in order to restart economic activity, which gave investors reason to start being optimistic again, but even as we are seeing progress in terms of […]
Read MoreEver since the coronavirus pandemic reached North American shores, investors have keyed on the virus more than any other issue in driving market direction. Nationwide shutdown and self-isolation orders brought the U.S. economy to a grinding halt in late February and forced the market to visit bear market lows by mid-March. Hopes that the worst […]
Read MoreTrade Setup Buy Target $20.31 Sell Target $23.91 Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules.
Read MoreBuy Price: $3.25 or better Sell Price: TradersPro Sell Signal NantHealth, Inc., together with its subsidiaries, operates as a healthcare technology company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solutions, including […]
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreTrade Setup Buy Target $56.73 Sell Target $69.14 AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Locum Tenens Solutions, and Other Workforce Solutions.
Read MoreStarting into a new month, a lot of analysts right now seem to be turning more optimistic. The last two months have seen a rally in the broad market indices that has a lot of people starting to talk about how much of the February-to-March drop to bear market conditions stocks have reclaimed. How much […]
Read MoreBuy Price: $5.70 or better Sell Price: TradersPro Sell Signal Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, rest of North and South America, and internationally. It principally offers VanishPoint safety products comprising tuberculin, insulin, autodisable, and allergy antigen syringes; IV […]
Read MoreIt’s a bit interesting to me to see that while Healthcare stocks in general have performed well during the COVID-19 crisis, the gains don’t extend to every single stock in that sector. That’s isn’t altogether unusual; after all, no matter what direction the trend of a given sector may be, there are always outliers that […]
Read MoreIn the early stages of the arrival and spread of COVID-19 in the United States, I wrote in this space about my belief that one of the best places a smart investor should focus their attention is on healthcare stocks, including companies in the pharmacy space. News media, economists and medical professionals have all turned […]
Read MoreTrade Setup Buy Target $4.31 Sell Target $5.36 Vaccinex, Inc., a clinical-stage biotechnology company, discovers and develops bio therapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab that is in clinical development […]
Read MoreTrade Setup Buy Target $7.32 Sell Target $9.63 Pfenex Inc., a clinical-stage development and licensing biotechnology company, focuses on developing protein therapies for unmet patient needs. Its lead product candidate include PF708, a therapeutic equivalent drug candidate to Forteo (teriparatide) for the treatment of osteoporosis.
Read MoreAs North America, and most of the world starts to move from broadly implemented lockdown and shelter-in-place mandates to gradually easing restrictions, I think it’s pretty normal to see corporate managers, market analysts, and talking heads commonly talking about the need for a COVID-19 vaccine to really understand the point where things can actually begin […]
Read MoreTrade Setup Buy Target $9.65 Sell Target $13.18 Amarin Corporation plc, a pharmaceutical company, develops and commercializes therapeutics for the treatment of cardiovascular diseases in the United States. The company’s lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe […]
Read MoreOver the last few weeks, I’ve been turning my attention more and more to companies in the Health Care sector, simply because as COVID-19 quickly turned from a distant, overseas problem to a global crisis that has now impacted the world on multiple levels, health care is among the few areas of the economy that […]
Read More